Cytek Biosciences Executive and Leadership Team

Wenbin Jiang, the Chief Executive Officer & Chairman at Cytek Biosciences, directs the overarching corporate strategy and long-term vision for the organization. By overseeing the development of Full Spectrum Profiling technology, the Chief Executive Officer & Chairman ensures the company maintains a competitive edge in the biotechnology sector. This leadership role involves constant engagement with the Board to align operational goals with market demands across North America, Europe, and Asia. Wenbin Jiang prioritizes the expansion of the Aurora and Northern Lights product lines to meet the evolving needs of scientific research institutions. Through rigorous oversight of global business activities, the Chief Executive Officer & Chairman fosters an environment of innovation and high-sensitivity analysis. This strategic focus supports sustained growth and reinforces the market position of the firm as a leader in advanced cell analysis solutions.

William McCombe, the Chief Financial Officer at Cytek Biosciences, manages the fiscal health and capital allocation strategies for the organization. By overseeing financial planning, reporting, and investor relations, the Chief Financial Officer ensures the company possesses the resources necessary to scale operations across global markets. This role involves analyzing the economic impact of product distribution in the European Union and Asia to optimize revenue streams. William McCombe works closely with the executive team to align budgetary priorities with the research and development goals of the firm. By maintaining rigorous financial controls, the Chief Financial Officer supports the long-term sustainability of the business model. This leadership position facilitates the growth of the company by securing the financial foundation required to deliver high-resolution cell analysis tools to scientific research institutions worldwide.

Ming Yan, the Chief Technology Officer at Cytek Biosciences, architects the research and development roadmap for advanced cell analysis instrumentation. By managing the engineering teams responsible for the Aurora and Northern Lights systems, the Chief Technology Officer drives the evolution of patented Full Spectrum Profiling technology. This role requires deep collaboration with scientific research partners to integrate high-resolution capabilities into existing laboratory workflows. Ming Yan oversees the technical integration of reagents and software to ensure seamless performance for end-users. By prioritizing high-sensitivity analysis, the Chief Technology Officer maintains the technological superiority of the product portfolio. This leadership function directly impacts the ability of laboratories to conduct complex research, ensuring that the company remains at the forefront of the biotechnology industry through continuous innovation and technical excellence.

Connie Wedel, the Chief People Officer at Cytek Biosciences, directs the human capital strategy and organizational development initiatives. By overseeing talent acquisition, employee engagement, and professional growth programs, the Chief People Officer ensures the company attracts top-tier experts in biotechnology and scientific research. This role involves fostering a culture of innovation that supports the development of complex cell analysis systems. Connie Wedel collaborates with department heads to align workforce capabilities with the strategic objectives of the firm. By implementing robust training and retention frameworks, the Chief People Officer maintains the operational efficiency of teams across North America and international offices. This leadership function directly impacts the ability of the company to execute its mission by building a high-performing workforce dedicated to advancing the field of cell analysis.

Valerie Barnett, the Chief Legal Officer at Cytek Biosciences, manages the legal framework and regulatory compliance for the organization. By overseeing intellectual property protection for Full Spectrum Profiling technology, the Chief Legal Officer ensures the company maintains its competitive advantage in the biotechnology sector. This role involves navigating complex regulatory landscapes in the European Union and China to facilitate the deployment of the Northern Lights CLC system for clinical use. Valerie Barnett works with the executive team to mitigate risk and ensure adherence to international standards in scientific research services. By providing strategic legal guidance, the Chief Legal Officer supports the expansion of the product portfolio into new markets. This leadership position is essential for protecting the innovations that define the company and ensuring that all business operations remain compliant with global regulations.